The top six were selected for inclusion
PLoS ONE 12 , e0185009 (2017)
Key Facts Lilly announced the results of two phase 3 trials on Thursday, saying it will file for FDA approval of the drugpotentially adding another GLP-1 to its lineupin the first quarter of 2027
Seek emergency care immediately if you experience dark/brown urine with severe muscle pain, as this may indicate rhabdomyolysis, a serious condition requiring urgent treatment
Daily Protocol: 1-2 mg subcutaneous injection, administered at the same time each day Alternative Protocol: 2 mg subcutaneous injection, 3 times per week Cycle Length: 12-16 weeks minimum for hair applications Break Period: 4-6 weeks between cycles Time to First Results: Subtle scalp improvements at 4-8 weeks, visible density changes at 12-16 weeks Timing considerations favor consistency above specific scheduling
Retatrutide works by activating multiple hormone receptors involved in appetite regulation, energy balance, and glucose metabolism